Cerus Announces Submission of Final Module in PMA App Process for INTERCEPT Platelets

By: via Benzinga
Cerus Corporation (NASDAQ: CERS) announced today that it has submitted the third and final module for its Premarket Approval (PMA) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.